General Western Blot Reagents
Abcam MitoTox Complex IV OXPHOS Activity Assay Kit
MitoTox Complex IV OXPHOS Activity Assay Kit
The product is subject to the following: Abcam Restricted Use Statement
Abcam Carbo x y-DCFDA N-succinimidyl ester, Fluorogenic esterase substrate, 50MG
MW 626.35 g/mol, Purity >96%. Cell-permeable, fluorogenic esterase substrate. Becomes hydrolyzed intracellularly to green fluorophore DCFA (ab145439) and covalently bonds to proteins.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Rp-8-Br-cGMPS, cGMP blocker, 500UG
MW 462.15 Da, Purity >98%. cGMP blocker. Competitively inhibits relaxation elicited by 8-Br-cGMP in isolated rabbit aorta contracted by phenylephrine at 30 μM.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Anti Nlrp3 Antibody Rm1021 AB283819-1ML
Anti Nlrp3 Antibody Rm1021 AB283819-1ML
The product is subject to the following: Abcam Restricted Use Statement
Abcam N6-Methyladenosine (m6A), Modified adenosine analog, 100MG
MW 281.27 g/mol, Purity >97%. Modified base. Adenosine analog methylated at the nitrogen-6 position. Abundant modification in mRNA, found within some viruses, and most eukaryotes including mammals, insects, plants and yeast. Also found in tRNA, rRNA, and small nuclear RNA (snRNA).
The product is subject to the following: Abcam Restricted Use Statement
Abcam BTBCT, Europium beta-diketone chelate, 250MG
MW 604.9 Da, Purity >95%. Europium β-diketone chelate. Provides 8 times improved detection sensitivity compared to BHHCT-(Asc5314
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tetramethylrhodamine-5-maleimide, Labeling reagent for protein thiols, 25MG
MW 481.5 g/mol, Purity >85%. Thiol reactive fluorescent probe for use in cytofluorescence. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BDSF (cis-2-dodecenoic acid), Diffusible fatty acid signal molecule, 10MG
MW 198.3 Da, Purity >95%. Diffusible fatty acid signal molecule. Acts as a bacterial virulence factor. Activates DSF-dependent responses. Inhibits germ tube formation in Candida albicans. Shows antifungal effects in vivo..
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-(3-O x ododecanoyl)-L-homoserine lactone, involved in quorum sensing, 20MG
MW 297.39 g/mol, Purity >98%. Autoinducer involved in quorum sensing by Pseudomonas aeruginosa. Member of N-acyl-homoserine lactone (AHL) family that regulate gene expression in gram-negative bacteria and are involved in the processes of bacterial quorum sensing.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 4-Methylumbelliferyl oleate, Fluorogenic substrate for lipases, 25MG
MW 440.61 g/mol, Purity >95%. Fluorogenic substrate for lipases, which can be used in aqueous solutions as well as several organic solvents.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AG 825, ErbB2 inhibitor, 10MG
MW 397.5 Da, Purity >96%. Selective ErbB2 inhibitor (IC₅₀ values are 0.15 and 19 μM at ErbB2 and ErbB1, respectively). Suppresses IL-6 induced STAT3 activation. Shows antiproliferative effects. Shows antitumor effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Acetyl-L-alanyl-L-glutamine, Polypeptide, 5G
MW 259.26 Da, Purity >98%. Polypeptide for proteomics research. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Acetyl-L-alanyl-L-glutamine, Polypeptide, 500MG
MW 259.26 Da, Purity >98%. Polypeptide for proteomics research. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Palmitoyl phosphatidylethanolamine, Endogenous lipid anorectic hormone, 5MG
MW 930.4 g/mol, Purity >98%. Endogenous lipid which significantly reduced food intake in a dose-dependent fashion when administered to rats and mice without causing taste aversion. Found to enter the brain (concentrating in the hypothalamus) when administered systemically and also reduced food intake when infused intracerebroventricularly (nanomolar concentrations), suggesting that mediation of effects is via the CNS. Chronic infusion resulted in a reduction of both food intake and body weight, suggesting that NAPE and long-acting NAPE analogs may be novel therapeutic targets for the treatment of obesity.
The product is subject to the following: Abcam Restricted Use Statement